Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine Bolus Doses for Post-spinal Hypotension in Preeclampsia
NCT05368415Phase 4Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of norepinephrine in hypotension (3 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Neonatal concentration of HCO3 from a sample of umbilical cord. Started May 2022; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05368415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05368415.